Synonyms: GSK'078 | GSK-2881078
Compound class:
Synthetic organic
Comment: GSK2881078 is an orally bioavailable, small molecule, nonsteroidal selective androgen receptor modulator (SARM). It was developed by GSK to treat age-related muscle atrophy (loss of skeletal muscle mass, quality, and strength) [1-2].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Clark RV, Walker AC, Andrews S, Turnbull P, Wald JA, Magee MH. (2017)
Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women. Br J Clin Pharmacol, 83 (10): 2179-2194. [PMID:28449232] |
2. Neil D, Clark RV, Magee M, Billiard J, Chan A, Xue Z, Russell A. (2018)
GSK2881078, a SARM, Produces Dose-Dependent Increases in Lean Mass in Healthy Older Men and Women. J Clin Endocrinol Metab, 103 (9): 3215-3224. [PMID:29982690] |
3. Zierau O, Kolodziejczyk A, Vollmer G, Machalz D, Wolber G, Thieme D, Keiler AM. (2019)
Comparison of the three SARMs RAD-140, GLPG0492 and GSK-2881078 in two different in vitro bioassays, and in an in silico androgen receptor binding assay. J Steroid Biochem Mol Biol, 189: 81-86. [PMID:30825507] |